• Since its launch in early 2019, Sequire has gained 1 million active investors, traders from 91 public companies
• New name — Sequire — represents platform’s main objective to acquire, secure investors for publicly traded companies
• Intelligent technologies set Sequire apart in world of data collection, reinforce Company’s focus on innovation and uniqueness

Consumer data—quickly becoming one of the most sought-after commodities in the world today—has never been so valuable. In response to this demand for consumer information, the investor intelligence and communications platform created by SRAX (NASDAQ: SRAX) unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies, allowing those issuers to use audience insights to capture the interest of existing investors and attract new investors. Since its launch in early 2019, Sequire has gained 1 million active investors and traders from 91 public companies (https://ibn.fm/CDFUJ). Originally named SRAX IR, the investor intelligence platform was renamed Sequire earlier this year; the powerful name represents the platform’s main objective to acquire and secure investors for publicly traded companies (https://ibn.fm/b8IvN). “We are thrilled to announce the new brand, giving the platform its own identity separate from SRAX,” said SRAX founder and CEO Christopher Miglino. “It’s also arriving at an opportune time as we are developing new intelligent technologies to further provide public companies the tools to reach and engage their shareholders.” These new intelligent technologies set Sequire apart in the world of data collection and reinforce the company’s focus on innovation and uniqueness in the marketplace (https://ibn.fm/Ko2ZH). For instance, Sequire enables its customers to engage with consumers in ways they’ve never been able to before, including the following:

• Know who’s buying and selling by unlocking key shareholder behaviors and trends from company data sets.
• Monitor training data in real time and obtain real-time market data, including level-two trading data, current sharing prices, volume, % change, and more; see biggest gains and losses over periods of time.
• Manage warrants and monitor expiring, outstanding warrants.
• Build full contact profiles on shareholders, including emails, phone numbers and social media accounts; engage with them directly in the platform.

In addition to these intelligent technologies, Sequire offers consumers a variety of options and tools that support them in their efforts to grow (https://ibn.fm/MkStN). Those include the following:

• A stock-for-ads program that includes a subscription to Sequire and credit for paid media in exchange for stock; designed as a way to help public companies engage with customers or clients and preserve cash during critical times.
• A virtual road show where companies can host one-on-one or one-to-many video and audio meetings to present their stories to new shareholders and provide quarterly and annual shareholder updates. After an event has ended, companies can track individuals who attended and monitor their investments in the company in real time.
• A mobile app that clients can use to monitor their shareholders’ behaviors wherever they go; the company intends to expand this feature set for both the desktop and mobile applications.

As the platform grows, Sequire’s ability to better understand which types of investors are willing to buy different stocks becomes increasingly defined, thus enabling the Company to better serve its clients. SRAX is building the largest and most reliable opted-in data sets across many industry verticals, accurately identifying target consumers for brands and companies in the CPG, investor relations, luxury, and lifestyle spaces, keeping those brands ahead in the competitive curve with high-quality data. As the company’s most recent offering, Sequire is a premiere investor intelligence and communications management platform that unlocks investor behaviors and trends, including who is buying and selling stock. Through the platform, companies can track their investors’ behaviors and trends and use those rich audience insights to engage existing investors and attract new investors across marketing channels. For more information about SRAX and Sequire, visit the companies’ websites at www.SRAX.com and www.MySequire.com, NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX 

• The Investor Summit Group’s Virtual Fall Summit will take place Nov. 16 through 18, providing a tried-and-tested formula for informing IR managers and investment-capitalized interests about available opportunities
• The summit provides a balance of market sectors in play, trending most heavily toward healthcare, consumer, financial and technology with energy, cannabis, industrial, and blockchain also represented
• Networking opportunities include live Q&A sessions, portal messaging and a virtual happy hour feature
• Summit organizers ensure quality investors through an eight-step vetting process and provide business attendees with concierge service in establishing a presentation and 1×1 schedule so attendees can “just show up”

The Investor Summit Group will present its tried-and-tested model for engaging business growth opportunities during its annual Fall Summit, which will take place via virtual means Nov. 16 to 18 for registered attendees.

Quality investors are the lifeblood of any public company, providing life-giving sustenance during growth phases particularly. The advent of the worldwide COVID-19 pandemic has altered the once-familiar networking corridors of investor relations, driving business management teams to question the need to jump on an airplane for face-to-face meetings whenever opportunities present themselves.

Investor Summit Group is experienced at delivering informational and networking opportunities that rely on quality connections through the utility of interactive online technology.

“While many investor conferences have transitioned to virtual format in recent weeks, The Investor Summit was far more of a success than others. I had a full slate of 1x1s, a well-attended presentation and no issues with the conferencing lines or other virtual aspects of the conference,” Ur-Energy Inc. Chairman and CEO Jeff Klenda wrote in one testimonial after an Investor Group event during the summer.

The summit provides the opportunity for IR managers and investment capital to discuss relevant topics in the investment space, delivering a concierge experience with hand-picked executives and vetted investors. Investor Summit uses an eight-step process to vet investors and guard against service providers posing as buy-side business.

The summit backs up its brand with a guarantee of a 50 percent-off ticket to a future conference if a business secures less than four meetings, and a $500 credit toward a future conference if any member of the investor pool turns out to be a falsely identified service provider.

The summit’s networking opportunities include interactions through live Q&A sessions, portal messaging and a virtual happy hour feature that includes stock pitches, round tables and lounge areas for organic interactions.

In delivering its concierge service, Investor Summit Group’s scheduling team calls qualified investors and builds company agendas. The virtual presentation is streamed live to investors and any other interests the company may wish to share its unique proposition with, and the presentations are accessible online for up to two months after the event to keep opportunities open.

Attendees can choose informational talks and set up meetings beginning three weeks ahead of the event, and the conference concierge team is available to help with planning.

Interested companies and individuals can register for the online summit by visiting www.InvestorSummitGroup.com.

• PwC’s Digital Trend Outlook 2020: Esports offers strategic, financial investors opportunity to see sustainable returns from the industry
• Investors should act now if they want to participate in the esports market
• Mobius Interactive poised to leverage growing interest of investors eyeing esports potential

In its report focusing on esports, the global consultancy firm PwC states that investors should act now if they want to invest in the esports market. As a company dedicated to bringing together loyalty programs, targeted gamification and product merchandising into one seamless package targeting the 18- to 38-year-old esports community, Mobius Interactive is poised to capitalize on a growing industry that looks to be well on its way to becoming mainstream.

The Digital Trend Outlook 2020: Esports report notes that, despite increasing consumer demand, investors are still reserved due to a lack of knowledge about the ecosystem of esports (https://nnw.fm/x9v9y). (https://ibn.fm/iaEcO). But COVID-19 has changed that, accelerating esports’ movement to mainstream and raising the sector’s visibility.

Esports turned online gaming into a spectator sport, growing considerably since its humble beginnings. Overcoming physical and spatial limitations of traditional sports, esports has exploded in the wake of the pandemic as it relies on digital platforms rather than actual presence.

Although still in its infancy, esports shows strong potential to monetize the growing and highly engaged fan base by generating revenues through multiple channels, including media rights, sponsorships, advertising agreements, publisher fees, merchandise sales, and streaming.

The economics of esports is superior to that of traditional sports. The Digital Trend Outlook research reports that the revenue side of the sector has an explosive scale with attractive costs per broadcast. These compelling features, combined with the changed consumer behavior and restrictive social distancing measures due to the virus outbreak, catapulted esports into the spotlight of the international funding scene.

In June, esports-related companies reported $196.8 million in investments, totaling $1.1 billion of disclosed investments this year to date. Recognizing a significant misconception about this growing sector among the broader investor audience, the consultancy firm states that it is crucial to educate stakeholders about the esports ecosystem and how the industry generates profits.

The industry is evolving as leading investors have started teaming up with top consulting firms to understand the esports market and learn how to benefit from it effectively. PwC believes that both strategic and financial investors have the opportunity to see sustainable returns from the industry.

As an online gaming operator featuring a variety of unique offerings catering to diverse demographic groups, Mobius Interactive is well positioned to leverage the growing interest as smart money is increasingly betting on esports. The company is partnering with award-winning eSports and iGaming platform Ultra Play and more than 600 VIP and master-gaming affiliates seeking to attract high-net-worth gamers worldwide. Led by management with experience in eSports and handling the launches of more 30 successful products within the last three years, Mobius Interactive is set out to become a notable player in this growing sector.

For more information, visit the company’s website at www.MobiusInteractive.Ltd.

NOTE TO INVESTORS: The latest news and updates relating to Mobius are available in the company’s newsroom at http://ibn.fm/Mobius

• Brain Scientific is a commercial-stage health care company aiming to modernize the brain diagnostics market by employing cutting edge technologies to bridge the widening gap in access to neurological care
• The company’s current offerings are the NeuroCap(TM) and NeuroEEG(TM) – two FDA-cleared devices delivered by wholly owned subsidiary MemoryMD Inc.
• The company’s intellectual property portfolio includes three patents in the U.S., China and Europe
• Brain Scientific is developing new products, including disposable EEG headsets for pediatric patients, long-term monitoring solutions and artificial intelligence options for monitoring and recording brain activity
• The company was selected as a finalist at the 2020 Epilepsy Foundation Shark Tank Competition
• The EEG device market is currently estimated at $956.1 million and is expected to grow to $1.6 billion by 2026, achieving a CAGR of 8.7%
• In the future, Brain Scientific intends to leverage AI and machine learning to map brain activities and providing data about different neurological conditions such as dementia, pre-Alzheimer’s and epilepsy

Brain Scientific (OTCQB: BRSF) is a commercial-stage health care company focused on developing innovative and proprietary medical devices and software. With a mission of modernizing brain diagnostics by employing cutting edge technologies to bridge the widening gap in access to quality care, the company offers two FDA-cleared products that provide next-generation solutions to the neurology market.

The company’s proprietary, clinical-grade neurological devices are supported by its intellectual property portfolio featuring patents in the United States, China and Europe.

Brain Scientific’s first commercialized devices, NeuroCap(TM) and NeuroEEG(TM), are designed to disrupt the current electroencephalogram (“EEG”) market by offering cost-effective and disposable substitutes to existing solutions, allowing medical professionals to collect diagnostic information quickly.

The company’s goal is to improve diagnostics by leveraging artificial intelligence and machine learning processes to analyze a database of brain readings as a method of detecting seizures and dementia. The company is also working to improve patients’ access to neurological care.

Headquartered in New York, Brain Scientific and its predecessor (and now wholly owned subsidiary, MemoryMD Inc.) was founded in 2015 and went public in 2018.

Brain Scientific’s first phase of development, from 2018 to 2019, saw the inception of portable, clinical-grade, easy-to-use neurological devices. The second phase, currently ongoing, aims to create cloud-based, secure infrastructure to transmit patient data between patients and their neurologists. The company’s third phase of development is scheduled for 2021-2022 and is expected to focus on the use of AI-assisted diagnostic analysis to increase the efficiency, consistency and accuracy of neurology specialists.

NeuroCap(TM) – Disposable EEG Headset

The NeuroCap is a disposable pre-gelled EEG headset featuring 22 electrodes and 19 active EEG channels, all adhering to the international 10-20 system. The NeuroCap was FDA-cleared in 2018. The headset can be used for recording EEGs in virtually any setting, including urban and rural emergency departments, neurology clinics, urgent care clinics, ICUs, nursing homes, assisted living facilities and remote clinical research labs.

Through a universal cable adapter, the NeuroCap is compatible with other EEG amplifiers. The cap also works in parallel with Brain Scientific’s NeuroEEG amplifier, initiating EEG studies in less than five minutes.

The company is currently seeking FDA approval for additional features for the NeuroCap, as the device has the potential to fill a gap in EEG testing availabilities during the current coronavirus pandemic: in October 2020, Brain Scientific filed an Emergency Use Authorization (“EUA”) application. The EUA is required for the rapid distribution of the NeuroCap device to emergency departments, intensive care units and other treatment centers to administer prescriptive EEGs safely on critically ill patients or those suspected of being diagnosed with COVID-19.

With more than 80 percent of hospitalized patients infected with COVID-19 displaying neurological symptoms, the NeuroCap could prove to be a valuable device by offering fast testing with limited contact between technicians and patients.

NeuroEEG(TM) – Miniature and Portable Wireless EEG Amplifier

The NeuroEEG is a compact, portable and affordable wireless EEG amplifier intended for prescription use. The 16-channel, FDA-cleared, clinical-grade device acquires, records, transmits and displays electrical brain activity for patients of all ages.

Both the NeuroCap and NeuroEEG are delivered by MemoryMD Inc., a wholly owned subsidiary of Brain Scientific.

Products in Active Development

Currently, Brain Scientific and MemoryMD are working on leveraging their existing products and drawing from ongoing research to develop and commercialize the next generation of solutions for the brain diagnostics market. The devices under development are being designed to address the following issues:

Routine EEG

• NeuroCap-8 is an 8-channel EEG cap. The reduced number of electrodes is vital in emergency room situations, where the time it takes to set up the EEG is critical.

Pediatric EEG

• NeuroCap Pediatric is positioned to become the first disposable and pre-gelled headset available for the pediatric market.

Long-Term Monitoring

• NeuroCap LTM for adult and pediatric patients is a disposable cap designed to monitor rhythmic and periodic patterns for up to 72 hours, providing essential diagnostic capabilities.
• NeuroEEG 24 Channel Amplifier is a portable and wireless amplifier with over 24 hours of battery life.

Artificial Intelligence

• Brain E-Tattoo is a minimally invasive four-channel EEG electrode designed for long-term monitoring.
• An AI database of brain biomarkers collects data on both normal and abnormal brain data to detect neurological diseases. The goal is for machine learning algorithms to enhance understanding of brain-behavior related to epilepsy, memory dementia and pre-Alzheimer’s diagnostics.

Telemedicine

Brain Scientific is expanding the vision for telemedicine in neurology. The company aims to address the current acute neurologist shortfall (20 states have less than 10 neurologists per 10,000 patients) through the use of teleneurology.

Partnership with Marketing Brainology

Brain Scientific has a longstanding partnership with Marketing Brainology, a neuromarketing firm using neuroscience approaches to understand consumer behavior. In 2019, Marketing Brainology conducted a study using NeuroCap and NeuroEEG to determine the most effective Super Bowl commercials.

“Thanks to Brain Scientific’s NeuroCap and NeuroEEG, we are able to better understand the art and science of the human decision-making process,” Michelle Adams, Ph.D, Founder of Marketing Brainology, stated in a news release.

In April 2020, Marketing Brainology again conducted a study leveraging Brain Scientific’s disposable EEG cap to determine how brains were reacting to COVID-19 messaging. Subjects were presented with multiple media impressions, and Marketing Brainology analyzed their responsive biomarkers. The results identified the most effective messaging for engaging with an audience during a crisis.

Market Outlook

The current global market for EEG devices is estimated at $956.1 million. It is expected to rise with a CAGR of 8.7% from 2019 to 2026, reaching $1.6 billion in value by 2026, according to Grandview Research.

In total, there are approximately 6,150 hospitals in the U.S., according to the American Hospital Association. Critically, though, just 254 of those hospitals are certified Level 4 Epilepsy centers with 24/7 EEG coverage. Since very few non-Level 4 centers have extensive EEG tech coverage, this creates a significant opportunity for Brain Scientific to bridge the gap by providing over 5,900 hospitals with lower cost amplifiers and disposable EEG caps.

The company also see opportunities to work with other businesses, such as EEG manufacturers hoping to package Brain Scientific’s solutions with their products, which could greatly expand Brain Scientific’s addressable target market.

Management Team

Dr. Baruch “Boris” Goldstein, Ph.D., is co-founder and Chairman of Brain Scientific. He is a seasoned executive with a proven talent for aligning global business strategies with established and emerging management teams. Goldstein’s growth-focused leadership style has helped him raise over $750 million in venture capital for the development of innovative companies and startups in diverse industries, including financial services, biomedicine, alternate energy and new materials, as well as groundbreaking work in artificial intelligence. His recent achievements include important advancements in neurology and unlocking the potential of AI correlations and machine learning applied to life sciences and medical research. He built a suite of first-to-market companies as a technology-oriented leader, including Ryah Medtech, Brain Scientific, GrapheneCA, E-Forex and Intelligent Video Systems. He also co-founded BrainRX, a company specializing in pre-Alzheimer’s diagnostics.

Dr. Nikolay Kukekov, Ph.D., is a Director of Brain Scientific and a partner at HRA Capital. Before joining HRA Capital, Kukekov was Managing Director of Healthcare Investment Banking at Summer Street Research. His scientific background includes a bachelor’s degree in Molecular, Cellular and Developmental Biology from the University of Colorado at Boulder. He earned his Ph.D. in neuroscience from Columbia University – College of Physicians and Surgeons in New York.

Stuart Bernstein is the company’s Vice President of Marketing. He was recently named to the role after spending the first part of his professional career in senior technical management roles with Fortune 500 companies such as NCR (NYSE: NCR), IBM (NYSE: IBM) and Control Data Corp. He was the CEO of BioSignal, an EEG medical device company. He is also a co-founder of several software engineering and telemedicine firms. One of them, Brain Saving Technology, is now Specialist on Call (SOC Telemed) – a leading telemedicine company that powers over 850 facilities for teleneurology, telepsychiatry and critical care telemedicine with over 200 physicians.

For more information, visit the company’s website at www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF 

• SGMD shareholder letter outlines building blocks of strategic vision
• Chan talks about two themes: geographic expansion for BudCars and Sugarmade’s move to cultivation operations
• BudCars is expanding into North San Francisco Bay area and wine country counties, then Los Angeles

In a letter to shareholders thanking them for their support, Sugarmade (OTCQB: SGMD) CEO Jimmy Chan outlined the “building blocks of a coherent and cohesive strategic vision” and noted that the company is putting in motion “key next steps to manifest that vision and drive strong and sustained shareholder value as a key emerging leader in the California cannabis marketplace” (https://ibn.fm/w96hm). 

“I want to highlight two themes that will help to drive our value proposition for shareholders over the intermediate term: geographic expansion for BudCars and our move to vertically integrate through the establishment of cultivation operations,” wrote Chan. “Together, they represent tangible catalysts driving both top and bottom line growth.”

In the letter, Chan noted that Sugarmade is working to “expand the scope, scale and reach of BudCars, a rapidly growing leader in the California cannabis delivery space — where we hold a 40% stake, with an option to take a controlling 70% stake, and where we are actively engaged in strategic and operational execution of the business.”

The letter outlined the dramatic growth BudCars has seen over the past six to eight months, noting that the company has consistently surpassed expectations in several key areas including customer acquisition and per-order volumes. “However, to fuel the next phase of our overarching vision, we must begin to expand our geographic reach,” Chan observed. 

“I have good news: that expansion is officially underway,” Chan continued. “We are expanding BudCars initially into the North San Francisco Bay Area and the Wine Country counties. That will be followed by our grand opening of BudCars Los Angeles, which we anticipate now will take place sometime in November.”

The letter noted that the move into the North Bay Wine Country area, which represents a more than doubling of the company’s total delivery territory, is “ripe with potential.” A recent “North Bay Business Journal” article reported that cannabis-related tax receipts from Sonoma County indicate that the area is seeing growth of 35% in the cannabis space. “As we begin to see tourism return in the wake of the global pandemic health crisis, we anticipate this region to represent one of the strongest bets as well, and we are excited about positioning BudCars to capitalize on that growth trend,” stated Chan.

The expansion into the wine country areas will be followed by the company’s grand opening in Los Angeles, slated for November. “Los Angeles is an enormous market for cannabis sales,” Chan explained. “It stands as perhaps the largest metropolitan cannabis marketplace on the planet. And we will be thrilled to see BudCars lay down roots and start taking market share in the area.”

The shareholder letter also noted that Sugarmade has secured a property zoned for cannabis cultivation and is working with regulators to move forward with plans to start its own cultivation operations. “This move will function to widen our margins on BudCars sales as well as to position Sugarmade to capitalize on growing demand in a chronically undersupplied marketplace,” the letter outlined. “Because of our access to end-market consumers through our BudCars distribution channel, we will also have an advantage over other cultivators in establishing a branded line of cannabis products, further supporting widening margins at each point in the chain.

“These are exciting times for Sugarmade. We have a rapidly growing business, and we are taking concrete steps now to build on that growth,” Chan concluded.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush(TM) and Budcars.com. Sugarmade is an investor in BudCars and a joint operator of BudCars’ first operating location in Sacramento, California. 

During early 2020, Sugarmade gained a 40% stake in BudCars and in the Sacramento delivery operations via the acquisition of a 40% stake in Indigo Dye Group (Indigo). Under the terms of Sugarmade’s agreement with Indigo, Sugarmade also acquired an option to purchase an additional 30% interest in Indigo, upon the closing of which would provide Sugarmade with a 70% controlling interest. As of the date hereof, this option has not yet been exercised; Sugarmade’s stake in Indigo remains at 40%, and there is no assurance that Sugarmade will exercise the option to acquire an additional 30% interest in Indigo. 

However, since late May 2020, Sugarmade has been actively involved in development of Indigo’s operations with power to direct the activities and significantly impact Indigo’s economic performance. Sugarmade also has obligations to absorb losses and right to receive benefits from Indigo. As such, in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification 810-10-25-38A through 25-38J, Indigo is considered a variable interest entity (“VIE”) of Sugarmade.

For more information, visit the company’s website at www.Sugarmade.com. 

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• Pure Extracts Technologies specializes in extraction of key molecules, oils from biomass
• Extracts are used to manufacture THC & CBD oils, edibles, infused beverages
• Edible and infused beverage products have been available in Canada since late 2019, taking up 13% market share within Canada’s specialty drug market
• Pure Extracts recently awarded standard processing license by Health Canada, which will enable the Company to produce clinical trial samples in its purpose-built facilities located near Whistler, Canada

Pure Extracts Technologies, a Pemberton, British Columbia-domiciled private plant extraction company, has witnessed its fortunes rise as of late. The Company’s unique business model is founded on four key pillars, namely the extraction of key molecules and oils from biomass as a tolling service, white-label product formulation, manufacturing and sales of its own ‘Pure Pulls’ brand and sales of its new functional mushroom product line –  ‘Pure Mushrooms’. With the Canadian market for edibles and infused beverages alone estimated to amount to over $2 billion a year and rising  (https://ibn.fm/6CNsm), end product manufacturers have found themselves increasingly hard-pressed in establishing a reliable supply chain to satisfy their growing demand for raw materials. Pure Extracts in turn have found themselves ideally positioned to benefit from the ongoing explosion in demand.

Pure Extracts’ current operations combine the Company’s legacy cannabis and hemp tolling experience, which seeks to convert hemp biomass into extracts such as CBD oil, distillates and isolates, with a growing product development operation which has seen the Company white-label the production of vape pens & edible products for third party retailers. The Company has recently sought to broaden the scope of its product development business through the creation of its own-branded proprietary product portfolio, referred to as ‘Pure Pulls’, an initiative which has seen the Company create 34 separate formulations. Pure Extracts plans on distributing these formulations through a wide network of dispensaries located across Canada (https://ibn.fm/0JiGX). 

Canada’s specialty drug market has historically been dominated by dried flower products, with only an estimated 13% market share held by extract products (www.PureExtractsCorp.com/Investors), such as CBD oils or edibles. However, that has largely been a function of the Canadian extract market’s relatively nascent nature, with most products having only been legalized and made available to the wider public as of December 2019. Pure Extracts looks to consolidate a hold on the extract sector given the relative lack of incumbent producers while capitalizing on the abundance of biomass currently available in the market – a factor which has allowed the company to significantly lower its raw material costs and expand its extract margins. 

“Pure Extracts plans to position itself as an extraction industry leader in terms of its Full Spectrum Oil (‘FSO’) quality,” says CEO Ben Nikolaevsky. “We can’t wait to show our LP partners the incredible quality extracted oil that we can produce, be it for medicinal or recreational usage.”

The Company has also looked to raise the quality and general perception of their capabilities, a pursuit which has recently seen the Company awarded with a Standard Processing License by Health Canada under the Cannabis Act, following an extensive and meticulous five-month application and vetting process (https://ibn.fm/Q98aQ). Following the award of the Health Canada licence, Pure Extracts will now be able to begin producing products for the B-to-B market in their purpose-built, British Columbia-based, extraction facility while adhering to EU Good Manufacturing Practices (“GMP”). This in turn will help ensure that molecules will be extracted to the highest possible quality and qualify for international exports to Europe and the rest of the world.

“We are thrilled to be commencing production in our new, EU-GMP compliant, purpose-built facility and are confident that our state-of-the-art extraction and processing equipment will produce the highest quality cannabis and hemp derived oil available on the market,” said Pure Extracts founder and COO Doug Benville following the Health Canada License approval.

For more information, visit the company’s website at www.PureExtractsCorp.com. 

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure

• The functional mushroom space has no clear leader, allowing for Rritual to target the role as the only premium brand currently on the market
• The company’s premium suite of products will be available first online through their website and the Amazon shop
• Rritual was the runner up for the Buyer’s Choice Award in the virtual ECRM presentation that connects companies with retail establishments creating business relationships
• The company was chosen for a special ECRM program on October 22, 2020, due to its award-winning status, connecting it to major retailers such as ALDI, Costco, Albertsons/Safeway, and Amazon
• The current functional food market is valued at more than $275 billion

Rritual Mushrooms is a private company that manufactures premium plant-based products including small-batch elixir powders and premium shots made from medicinal mushrooms and adaptogenic herbs. 

Rritual’s mission is to help each and every person meet the demands of modern life with style and ease through mushroom adaptogen products, slated to be sold online and through brick and mortar establishments. Through its management team, the company has developed connections with leading retailers and other establishments to begin rolling out its product offering. The first products will be available online through the Rritual website and an exclusive Amazon shop.

Recently, Rritual took part in a virtual program organized by ECRM, an international organization that connects suppliers and buyers. The virtual program, called “The Whole Body and Mind Wellness,” was the first time any ECRM program curated meetings related specifically to wellness lifestyle. Its goal was to connect major retailers with brands that support the growing consumer interest in health and fitness (https://ibn.fm/zAhLv). 

Rritual was selected as the runner up for the Buyers Choice Award for its Reishi Relax Elixir, picked by retail buyers from dozens of entries. “Retail buyers selected Rritual for the award because our packaging, design and formulation stood out amongst the dozens of products they evaluated,” CEO David Kerbel said. “Their stamp of approval on our product reinforces what we know: that Rritual products will capture the attention of shoppers on shelves and in e-comm, supporting our anticipated year-one growth.”

Due to this award, Rritual was invited to participate in a special ECRM program that took place on October 22, 2020. This event included major retailers such as ALDI, Costco, Albertsons/Safeway, and Amazon. 

Rich in polysaccharides, triterpenes, fatty acids, and amino acids, infused with Ashwagandha root to improve sleep quality and promote stress support, Reishi Relax is just one of the products included in Rritual’s premium suite. The other two leading products are Lion’s Mane Focus, paired with Rhodiola root to support cognitive function and overall brain health, and Chaga Immune, full of bioactive polysaccharides and infused with Eleuthero root to create an optimal environment for the body’s immune system.

The company is still in its early development stages, but it has the potential to become the leading force in the functional mushroom and foods market, amid a vacuum of premium brands in the space. The current functional food market is valued at more than $275 billion, with a global shift supporting wellness and the 7.9% CAGR forecast through 2025.

The demand for functional mushrooms is also forecasted to rise from $23 billion to an increase of $34 billion by 2024. Worldwide, the market is expected to reach $50 billion by 2025 due to the popularity of the superfood’s unique properties and the proven abilities to increase cognitive function, boost immunity, and help manage stress.

For more information, visit the company’s website at https://Investors.WeAreRritual.com. 

“Mental Fitness is a Daily Ritual”

NOTE TO INVESTORS: The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at http://ibn.fm/Rritual 

• Mining district in Chile has been in sharp decline, hit particularly hard in 2020
• Government supports revitalization, has proposed a series of tax breaks for investors
• GOH drilling program anticipated to begin in January 2021

Formerly known as Altum Resources Corp, GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF) is a Canadian junior exploration company active in the Maricunga Gold Belt of Northern Chile. The company has entered into agreements to acquire seven promising gold projects. The company’s goal is to identify and capitalize on valuable precious metal projects in mineral-rich districts with stable political jurisdictions. 

In April 2020, GoldHaven entered into an agreement to purchase the Rio Loa and the Coya projects. A few months later, in August, GOH entered into an agreement to acquire five potential gold projects in the same region of Northern Chile: the Alicia, Roma, Jacqueline, Valley and Condor projects.

The gold-rich Maricunga Belt, where all seven projects are located, straddles the border of Chile and Argentina. It is approximately 150 kilometers long and 30 kilometers wide. The mining district has seen a sharp decline over the last decade and has been hit particularly hard in 2020. 

According to an article in the “Northern Miner” (https://ibn.fm/nvvSj), new projects in the area could bring revitalization to the Chilean economy, which has suffered greatly due to the coronavirus pandemic. The government is supportive of these efforts and wants to see these new jobs created. A series of tax breaks for investors has been proposed that includes instant depreciation of capital investments begun by December 2022 and a tax credit worth 25% of the salary of each new job created. 

This government support of mining is not new. The Chilean Economic Development Agency launched an initiative over a decade ago to finance exploration projects in the country. A fund of $150 million was set aside to develop exploration and boost mining prosperity, with an end goal of becoming a world leader in the industry. To do so, the Chilean government began to promote investments that respected the environment, community and local workforce (https://ibn.fm/UM4kx). The government is looking for companies such as GoldHaven to come in and help revitalize the economy. 

GOH has identified four of its seven properties (the Rio Loa, Coya, Alicia and Roma projects) as high-priority targets and plans to begin its drilling program in January 2021. These targets were identified through mapping, geochemical sampling, satellite imagery and location relative to existing discoveries. 

For more information, visit the company’s website at www.GoldHavenResources.com.

NOTE TO INVESTORS: The latest news and updates relating to ATUMF are available in the company’s newsroom at http://ibn.fm/ATUMF 

• Mulch Manufacturing has signed mulch supplier contract with Vero Beach, Florida
• This — and other recent contracts — made possible due to SGTM’s recent completion of construction on its Florida Waste Management facility
• Sustainable Green Team was created by bringing together three industry-leading companies

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, has announced that its wholly owned subsidiary will be the official mulch supplier for Vero Beach, Florida (https://ibn.fm/OunIk). Mulch Manufacturing has signed a one-year contract with the Florida city, with two additional one-year extensions. 

The Vero Beach contract is the most recent in a string of contracts awarded to Mulch Manufacturing, one of the largest producers of packaged mulch products in the country. Earlier this month, the company obtained mulch contracts from three Circle K convenient store divisions (https://ibn.fm/xBzrT). A week earlier the SGTM subsidiary landed a mulch and soil purchase agreement with the Kroger Co. to provide material for the 94 stories in its Louisville, Kentucky division (https://ibn.fm/s6yJf). And that contract came on the heels of the company being awarded a 2021 mulch packaging contract renewal from Menards Inc. (https://ibn.fm/Ek8QH).

“We are pleased to be awarded this new government contract opportunity,” said SGMT CEO and director Tony Raynor (https://ibn.fm/MTzQp). “And it’s all thanks to our recently completed construction in the Waste Management (‘WM’) facility in central Florida.” 

The July 2020 construction at the facility in Apopka, Florida, included a dual line mulch bagger and fully automated electric grinding screen operation. With the new fully electric equipment coming online, the company can increase its mulch production by four million bags per year within one shift. In addition, the new operations will allow full vertical integration at WM’s landfill by utilizing unused debris that is typically buried. Now the unused debris can be reused and branded into a premium mulch product onsite. 

“This is a pivotal advancement,” said Raynor commented. “With our strong relationship with Waste Management, we are progressing toward achieving true green sustainability.

Mulch Manufacturing is part of the Sustainable Green Team LTD, which was created by combining the resources of three companies that were leaders In their specialties: Mulch Manufacturing, National Storm Recovery and Central Florida Arbor Care. As a result, SGMT has the expertise to address the needs of each of the combined customers with a new level of quality and cost effectiveness.

The Sustainable Green Team, through its subsidiaries, provides tree services, debris hauling, and removal and bio-mass recycling, as well as manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation. 

To learn more about the Sustainable Green Team, view the company’s investor presentation at https://ibn.fm/vLpB2. For more information about Mulch Manufacturing, visit www.MulchMfg.com.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM 

• Backed by an anonymous donor, Berkeley launches a center for psychedelic science and public education
• Berkley follows examples of other notable universities such as Johns Hopkins in Maryland, Imperial College in London, and Canadian Centre for Psychedelic Science
• As an innovative company focusing on psilocybin, CYBIN is set to capitalize on growing academic, commercial attention

UC Berkeley is joining other prominent academic institutions, including Johns Hopkins University in Maryland and Imperial College in London, to accelerate the scientific research of psilocybin by launching a new center focusing on the compound (https://ibn.fm/CL4wX). As a mushroom life science company that expects to launch psilocybin-based products in jurisdictions where the substance is not prohibited, CYBIN Corp. will benefit from the growing research interest in psilocybin, bringing the compound to the mainstream. Five decades after a government ban on psychedelic research, UC Berkeley is opening its doors again to psychedelic science and public education. Supported by $1.25 million in seed funding from an anonymous donor, the prestigious university has announced the launch of the UC Berkeley Center for the Science of Psychedelics. The center aims to conduct research using psychedelics to explore cognition, perception, and emotion and their biological bases in the human brain. The center will also create a program to educate the public about the once-controversial and now rapidly advancing psychedelics research. “There’s never been a better time to start a center like this. The renewal of basic and clinical science with psychedelics has catalyzed interest among many people,” said UC Berkeley neuroscientist David Presti, who is also one of the center’s co-founders. Presti has teamed up with other co-founders to conduct studies and explore the potential of psilocybin and other psychedelic compounds. Their research will examine the effectiveness of treating highly prevalent mental disorders including anxiety, depression, post-traumatic stress disorder and substance abuse. Initial experimental studies will use psilocybin, the psychoactive compound found in “magic” mushrooms. “Some of these studies have produced striking results in cases that are otherwise resistant to more conventional medical treatment. This suggests that psychedelic compounds may offer new hope for people suffering from these disorders,” said UC Berkeley neuroscientist Michael Silver, who also serves as an inaugural director of the newly launched Center for the Science of Psychedelics. Likewise, Rotem Petranker, co-founder and director of the Canadian Centre for Psychedelic Science,is a clinical psychology PhD student with John Eastwood’s lab at York University (https://ibn.fm/be28y). His main research interests are sustained attention, emotional regulation and creativity, all of which are ostensibly affected by psychedelics. Petranker is passionate about establishing a rigorous framework for the study of psychedelics using open science principles. His clinical interests include disorders amenable to psychedelic psychotherapy, including mood disorders and OCD. Pretranker’s partner, co-founder and director Thomas Anderson, is a PhD candidate studying cognitive neuroscience at the University of Toronto in Canada. Anderson is a strong proponent of open science and publicly communicating scientific findings. Dedicated to supporting clinical studies across North America and other regions through strategic academic and institutional partnerships, including the Canadian Centre for Psychedelic Science, CYBIN Corp. is poised to benefit from the increasing research interest in psilocybin. As an early entrant into a rapidly growing field, CYBIN seems well positioned to leverage the growing recognition of psychedelic research leading to eventual public acceptance with the potential to propel the whole industry to the new level. CYBIN is an innovator in the stagnant pharmaceutical market, where it aims to become the first life science company to bring psiloybin medicine targeting major depressive disorder to market (https://ibn.fm/Y48W6). For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBIN are available in the company’s newsroom at http://ibn.fm/Cybin